YungShin Global Holding Corporation

YungShin Global Holding Corporation is a prominent Taiwan-based investment holding company that manages a comprehensive portfolio of subsidiaries in the pharmaceutical and healthcare sectors. Established in 2011 to consolidate the operations of the YungShin Group, the company oversees the development, manufacturing, and marketing of generic drugs, active pharmaceutical ingredients (APIs), and animal health products. Its primary subsidiary, YungShin Pharmaceutical, is a leader in the Taiwanese market and maintains a strong international presence with facilities in China, Malaysia, and the United States. The group is committed to high-quality standards, with multiple plants holding PIC/S GMP certifications. YungShin's diverse product line spans various therapeutic areas, including cardiovascular, metabolic, and infectious diseases, as well as consumer health and cosmetics.